about
AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, inclu...
Read More
21.20
0.59
(2.86%)
50,892
XNAS Volume
XNAS 03 Sep, 2025 10:30 AM (EDT)
Low Financial Strength
Expensive Valuation
Technically Neutral
Momentum Trap
These stocks are the ones with poor quality and also financials and technical ranging from bad to medium score. This indicates that investors should be highly watchful with these stocks.
View Similar
Embed DVM
AnaptysBio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..